TCS 1102 - CAS# 916141-36-1 Catalog No.:M10520-10 ClH/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19

ClH/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19

20-72 hours) treatment causes a G0/G1 phase block as well as apoptosis

MALT1-MI-2 (MI-2)

could modulate the fibrogenic signal transduction of TGFβ-Smad pathway

TCS 1102 - CAS# 916141-36-1 Catalog No.:M10520-10 ClH/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19TCS 1102 is a potent, dual orexin receptor antagonist (Ki values are 0. 2 and 3 nM for OX2 and OX1 receptors respectively). TCS 1102 inhibits ADL orexin B mediated locomotion following i. p. administration in vivo and blocks orexin A (Cat. No. 1455) mediated increases in feeding behaviour. Product information CAS Number: 916141 36 1 Molecular Weight: 470. 59 Formula: C27H26N4O2S Synonym: TCS1102 TCS 1102 Chemical Name: (2S) N {[1,1' biphenyl] 2 yl} 1